Investigative methods examine radiosensitivity and genotoxic effects in cancer patients, suggesting improved treatment outcomes.
A variety of different methods have been used to investigate the radiosensitivity of cancer patients treated with radiotherapy in order to predict the risk for developing adverse effects, improve the therapeutic success, and patient’s quality-of-life.The most investigations were realised with peripheral blood cells from head and neck cancer, breast cancer, and prostate cancer patients. The irradiation response of patient-derived lymphocytes has been associated with acute and late normal tissue reactions to radiotherapy. The approaches which were used include measurements of cytotoxic effects (including apoptosis and cell cycle delay), identification and analyses of specific genes and use of methods which reflect genotoxicity and DNA repair. The most frequently employed approaches that detect damage of the genotoxic material which is induced by ionizing radiation (double strand breaks and oxidative damage) are chromosomal aberration (CA) analyses of metaphase cells, micronucleus (MN) experiments detecting structural and numerical CA, γH2AX assays which can be used to measure double strand breaks, and single cell gel electrophoresis (SCGE) assays reflecting single and double DNA strand breaks....
No takes yet. Share an insight, caveat, or question.
Matić et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: